€18,50
AreaCBD, a farming company based in Montepulciano (SI), is a benchmark in Tuscany for high-quality CBD flower and oils. The 2025 harvest, organic and natural, reflects this philosophy: advanced genetic research, mineral-rich soils, water from an ecological lake and targeted organic fertilization result in flowers cared for in every detail.
Blue Nightmare is instantly recognisable for its fresh, balsamic aroma, with notes of mint, pine and subtle fruity nuances. The buds are compact, dark and highly resinous, with a deep green colour crossed by bluish hues and a dense layer of trichomes that enhances its terpene profile. It’s a strain designed for those who appreciate clean, fresh notes without giving up intensity and character.
A wave of balsamic freshness, ideal for regaining clarity and balance.
Blue Nightmare was created from the cross of two iconic genetics: Blue Dream, known for its bright, fruity character, and Nightmare OG, appreciated for its balsamic notes and aromatic depth. Originating from the West Coast, this combination has been selected in a CBD expression by AreaCBD, keeping the aromatic core of the original while maintaining THC levels within legal limits. For the 2025 harvest, grown outdoor in the fields around Montepulciano, Blue Nightmare delivers a clearly defined fresh, balsamic profile and stands out as one of the most recognisable CBD flowers in the AreaCBD line.
The THC and CBD values shown on the label refer to the tested sample from the batch and may vary slightly from one package to another. It is important to remember that the quality of CBD flower does not depend solely on the percentage of CBD or THC, but on a combination of factors: the genetics, the care taken during cultivation, drying and curing methods, storage conditions and the flower’s aromatic profile. A well-grown, fragrant and intact product can be far more satisfying than CBD flowers with higher numbers on paper but less attention to detail.
THC: <LOQ
(<LOQ below the limit of quantification)
THCA: 0.50%
CBD: 0.29%
CBDA: 12.96%
View the full lab report